Zydus Lifesciences has informed that it enclosed a copy of press release dated June 9, 2023 titled ‘Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in Non-Alcoholic Fatty Liver Disease (NAFLD) patients with comorbidities.’
The above information is a part of company’s filings submitted to BSE.